News & Updates

A single dose of esketamine appears to enhance the efficacy of oral antidepressants for treating patients with major depressive disorder (MDD) who are experiencing fluctuating symptoms, as reported in a small study.

Comorbid major depressive disorder and rapid eye movement sleep behaviour disorder (MDD-RBD) is a common subtype of MDD. These patients and their first-degree relatives (FDRs) are at risk of neurodegeneration, researchers from the Chinese University of Hong Kong (CUHK) have reported.

Individuals with attention-deficit/hyperactivity disorder (ADHD) appear to be at increased risk of being involved in cases of violence, such as intimate partner and sexual violence, according to the results of a meta-analysis.

Young adults with memories of childhood maltreatment have a greater number of depressive or anxiety episodes in adulthood vs those with official court records but not memories of such maltreatment, a large longitudinal study has found.

Combinations of serum biomarkers relating to cortisol, total cholesterol, and folate, as well as interleukin (IL)-1β and homocysteine, help improve the predictability of suicide attempt and increased suicidal severity, respectively, among individuals being treated for depression, according to a study.

Risperidone use among patients with schizophrenia appears to confer some protection against the risk of kidney function decline, as reported in a study.